Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer.
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
View in:
PubMed
subject areas
Breast Neoplasms
Female
Heart Failure
Humans
Prognosis
Stroke Volume
Ventricular Dysfunction, Left
Ventricular Function, Left
authors with profiles
Lawrence H. Kushi, ScD
Carlos Iribarren, MD, MPH, PhD
Marilyn L. Kwan, PhD